+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06316557

Study of Intermittent Theta Burst Stimulation on the Cerebellum to Improve Cognitive Function After Ischemic Stroke

Led by Zi-Xiao Li · Updated on 2025-07-02

70

Participants Needed

1

Research Sites

39 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effectiveness and safety of intermittent theta burst stimulation iTBS, a type of repetitive transcranial magnetic stimulation, applied to the cerebellum in individuals with post-stroke cognitive impairment. The study aims to determine if iTBS can improve cognitive function after stroke and to assess its safety in this population. The trial compares active iTBS treatment to a sham stimulation control group. Participants will receive iTBS or sham stimulation on the cerebellar hemisphere opposite to the stroke lesion twice daily for seven days. Both treatments use the same device parameters and positioning to maintain the studys randomized and blinded design. This intervention period is followed by monitoring and evaluation to assess outcomes over time. During the study, participants will undergo assessments to measure cognitive function and safety, with a primary outcome measured three months after treatment completion. Safety monitoring occurs daily from day one to day seven. The trials total duration includes the seven-day treatment period plus follow-up assessments to track improvements in cognitive abilities and any adverse effects.

CONDITIONS

Brief Title

HOPE From the Cerebellum: TMS-Induced Cognitive Recovery After Stroke

Research Team

W

Weili Jia, Dr.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here